Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 667 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of Illinois Chicago Clear all

Conditions: Patients Receiving Physical Therapy
Interventions: Strength education video, standard PT care; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Down Syndrome
Interventions: Hand grip exercise and lower body negative pressure; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 45 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mental Disorder
Interventions: Healthy ReStart, Services as Usual; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Head and Neck Cancer, Head Cancer, Neck Cancer
Interventions: RiMO-301, Pembrolizumab, Radiation, Surgical resection; Drug · Radiation · Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Physiological Reactivity to Cues, Physical Exercise
Interventions: 36-session targeted physical exercise program delivered twice weekly; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure
Interventions: Digoxin Dosing per Nomogram, Digoxin; Other · Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 22 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell Disease, Diabetes Mellitus
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Fall Prevention
Interventions: Task-Specific Balance Training, Treadmill Perturbation Training, Conventional Balance Training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years to 90 Years
Enrollment: 315 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment
Interventions: Total Marrow Irradiation, Melphalan, Filgrastim (G-CSF), Autologous transplant; Radiation · Drug · Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pancreatic Cancer
Interventions: Lidocaine Hydrochloride, Saline Solution for Injection; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression
Interventions: CATCH-IT, TEAMS; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 13 Years to 19 Years
Enrollment: 636 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 2 Diabetes
Interventions: Observational Study: Relationships Among Glucose, Physical Activity and Environmental Influences; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Advanced Solid Tumor, Metastatic Cancer
Interventions: Ablative radiation treatment; Radiation
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Sclerosis, Major Depressive Disorder
Interventions: POWER-MS, FLEX-MS; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 64 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Information Dissemination, Interprofessional Relations
Interventions: Discharge communication software, Usual care discharge process; Device · Other
Lead sponsor: Agency for Healthcare Research and Quality (AHRQ); Federal
Eligibility: 18 Years and older
Enrollment: 631 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Hemorrhoids
Interventions: HET Application; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hot Flushes, Hot Flashes
Interventions: Bupivicaine, Saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 70 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sickle Cell Anemia
Interventions: Regadenoson, Placebo; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 10 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 12
States / cities: Oakland, California • Chicago, Illinois • Baltimore, Maryland + 7 more

Conditions: HIV Infections
Interventions: Project ICARE, HCT; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders
Interventions: Injectable extended-release buprenorphine, Sublingual buprenorphine-naloxone; Drug
Lead sponsor: Yih-Ing Hser; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 7
States / cities: El Dorado, Arkansas • Garberville, California • Gibson City, Illinois + 4 more

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Risperdal Consta (drug), Social Skills Training; Drug · Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 55 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 2
States / cities: Chicago, Illinois • White Plains, New York

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: Time restricted feeding (TRF), Daily calorie restriction; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tobacco Use
Interventions: Brief behavioral counseling; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 21 Years and older
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type1diabetes
Interventions: FREE; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 30 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Does a Video-based Education Tool Related to Strengthening Result in Different Functional Outcomes Compared to Traditional Physical Therapy Education for Patients?

Blood Flow in Individuals With Down Syndrome

Healthy ReStart Intervention to Improve Health and Functioning

RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer

Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care

Glucose Metabolism in Sickle Cell Disease

Aging and Task-specific Training to Reduce Falls

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

Lidocaine Infusion in Pancreatic Cancer

PATH 2 Purpose: Primary Care and Community-Based Prevention of Mental Disorders in Adolescents

Enhancing Diabetes Care: Exposome &Amp; Sensors

STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Value of Technology to Transfer Discharge Information

HET Bipolar System: Validation of Outpatient Hemorrhoid Treatment

Stellate Ganglion Block (SGB) For Women for Breast Cancer

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Project ICARE: Intervening for Community Awareness, Respect, & Empowerment

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

Time Restricted Eating for the Treatment of Type 2 Diabetes

Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes

A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With Type 1 Diabetes